Status:
UNKNOWN
Validating a Modified COMPASS 31questionnaire for Treatment Outcomes
Lead Sponsor:
Brooke Army Medical Center
Collaborating Sponsors:
The Defense and Veterans Brain Injury Center
The University of Queensland
Conditions:
Headache, Migraine
Persistent Post Traumatic Headache
Eligibility:
All Genders
18-64 years
Brief Summary
Eligible participants will complete the COMPASS 31 (year), modified COMPASS 31(one month) and the NSI (one month) questionnaires at baseline and complete the modified COMPASS 31 and the NSI after usua...
Detailed Description
The Composite Autonomic Symptom Score (COMPASS 31) is a validated questionnaire designed to measure self reported autonomic symptoms in the last year in individuals with migraine and post-concussive s...
Eligibility Criteria
Inclusion
- Patients who present to the BAMC\_BIRS clinic for treatment of headache between the ages of 18-64.
Exclusion
- Normal composite autonomic symptom score.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 20 2023
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT05302479
Start Date
April 15 2022
End Date
September 20 2023
Last Update
July 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brooke Army Medical Centre
Houston, Texas, United States, 78234